Large SPORE Grant Focuses on Developing Biomarkers to Predict Melanoma Immunotherapy Treatment Outcomes
Four promising projects aim to discover which patients will experience benefits or toxicity.
Two Promising Clinical Trials Target Difficult Brain Tumors with Innovative Treatments
These phase 2 trials provide new options for treating glioblastomas and meningiomas.
